Back
![](https://s3.ap-southeast-1.amazonaws.com/buckets.epicareer.com/employer/logo/20240517124304-2279468-intracellular-therapies.jpg)
Intra-Cellular Therapies
Founded by : Sharon Mates, 1 January 2002
New York County, United States
More than 250 employees
About the Company
Intra-Cellular Therapies, Inc. is a biopharmaceutical company that develops and commercializes novel drugs for the treatment of central nervous system (CNS) disorders. The company's lead product candidate, lumateperone, is a first-in-class molecule that targets multiple CNS receptors and has demonstrated efficacy in treating schizophrenia and bipolar disorder. In addition to lumateperone, the company has a pipeline of other CNS drug candidates, including ITI-214 for Parkinson's disease and ITI-333 for Alzheimer's disease. Intra-Cellular Therapies has partnerships with major pharmaceutical companies and has received funding from the National Institute of Mental Health.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Intra-Cellular Therapies’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Biotechnology
- Sub-Industry: Biotechnology
Videos and Photos
Company Address
430 East 29th Street New York, NY 10016 United States
Source : Google maps